Combination therapy with amlodipine or trichlormetiazide added irbesartan in hypertensive patients with diabetes

Phase 4

• Conditions: Hypertension with diabetes

• Registration Number: JPRN-UMIN000007297
• Lead Sponsor: Control of organ function, Kanazawa University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-02-15
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Not provided

Exclusion Criteria

1)Hypersensitivity to or contraindication of irbesartan,trichlometiazide and amlodipine 2)within 3 months after onset of acute myocardial infarction 3)Symptomatic (NYHA3or4)congestive heart failure 4)Severe renal dysfunction or severe liver dysfunction 5)Pregnancy or its possibility 6) subjects whose doctor in charge do not agree to join the trial patients judged as inappropriate for the sutudy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1.blood pressure 2.Renal function(urinaru albumin eGFR)

Secondary Outcome Measures

Name	Time	Method
1.to evaluate the therapy if it could better responded to the patients with low or high sodium 2.PAC